Scarica l'app Stockscreener
59.40
5.86%
3.29
Exact Sciences Corp Borsa (EXAS) Ultime notizie
Tidal Investments LLC Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Toronto Dominion Bank - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $72.00 at Bank of America - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Groupama Asset Managment Acquires Shares of 1,204,952 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corp reports results for the quarter ended in September 30Earnings Summary - XM
AAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening Rates - Yahoo Finance
Pier Capital LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Soros Fund Management LLC Boosts Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Lil Jon Remixes Iconic ‘Get Low’ Hit To Promote Colon Cancer Screenings - Black Enterprise
Polar Asset Management Partners Inc. Acquires 45,800 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Cerity Partners LLC - MarketBeat
Exact Sciences Corp (EXAS) Shares Up 4.18% on Dec 4 - GuruFocus.com
CFRA raises Exact Sciences to buy, target to $72 from $48 - Investing.com
Cinctive Capital Management LP Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
The Manufacturers Life Insurance Company Acquires 35,927 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Beacon Investment Advisory Services Inc. Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences and Lil Jon Partner on Get Low #2 Campaign to Encourage Colon Cancer Screening - El Diario NY
Lil Jon partners with Exact Sciences to raise awareness for colorectal cancer screening - The Atlanta Voice
Exact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer Screening - Mid Florida Newspapers
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
30,536 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Fred Alger Management LLC - MarketBeat
392,139 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Erste Asset Management GmbH - MarketBeat
Bellevue Group AG Grows Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Wasatch Advisors LP Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Braidwell LP - MarketBeat
Northwest & Ethical Investments L.P. Sells 36,242 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Spyglass Capital Management LLC Has $95.17 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Fisher Asset Management LLC Sells 36,302 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
EXASExact Sciences Corp Latest Stock News & Market Updates - StockTitan
Soros Capital Management LLC Acquires Shares of 51,700 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences stock lifted by TD Cowen, sees 10% revenue growth potential from CG+ - Investing.com Canada
Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) - AOL
Exact Sciences stock outlook improves with Cologuard Plus launch and Medicare reimbursement - Investing.com
Exact Sciences stock rating maintained outperform as Medicare pricing boosts CG+ outlook - Investing.com
Exact Sciences stock up 10%, BTIG raises target after 16% price increase for Cologuard Plus - Investing.com
Exact Sciences shares keep outperform rating on Medicare fee schedule boost - Investing.com
S&P 500 Futures Climb in Premarket Trading; Woodward, Exact Sciences Lead - Barron's
Exact Sciences to Participate in December 2024 Investor Conferences - BioSpace
Exact Sciences to Participate in December Investor Conferences - Business Wire
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024 - El Diario NY
Exact Sciences to present 10 abstracts on Precision Oncology portfolio at SABCS - TipRanks
Exact Sciences Advances Breast Cancer Care with the Oncotype DX - Business Wire
Exact Sciences to Present 10 Key Studies on Breast Cancer Test Effectiveness at SABCS - StockTitan
Exact Sciences Co. (NASDAQ:EXAS) Position Trimmed by Victory Capital Management Inc. - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Buys Shares of 32,194 Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences data show multi-biomarker class approach improves MCED cancer detection - The Cancer Letter
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com India
Swiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Madison-based Exact Sciences reports Q3 results short of analysts’ expectations - Chippewa Herald
EULAV Asset Management Boosts Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey
Exact Sciences Corp (EXAS) Shares Up 8.93% on Nov 19 - GuruFocus.com
Exact Sciences Co. (NASDAQ:EXAS) Sees Large Drop in Short Interest - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community - El Diario NY
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):